COSCIENS Biopharma Inc (CSCI)

[livendi]

aezs will be doing that,like they did the adult test although so far the adult test hasnt really sold too well probably due to ins companies in usa being cheap,the child test will be different because its for an unmet need being there is no way to test kids for ghd,still the key is other uses for macrilen,again 2 phase 3 in usa for 2 different indications and preclinical for l gehrig disease,also again the child test will be big also,the covid and other licensing deals are also important and im sure some will become valuable,if we could just get the covid pill vaccine in front of fda and eu with fab preclinical results,i think thats why that is taken so long,they want much better results than whats out there and also they coud be trying to cover the variances of covid also that are becoming more of a problem,with all these things happening aezs is bound to bounce well over 3 and more on the right news,it sucks it has dropped from 3 but long term u will at least double your money imo min but again its going to take some time,if aezs nails this covid pill what do u think the pps will climb 2,i say min 10 bucks on fab preclinicals and submission to fda and eu,im not saying this will be a 50 $ stock but 10 is easilt attainable and maybe even 20 if most catalysts come to fruition,again just hold like i did when i was 90% down in aezs and ended making good money in the end,ive loaded the boat again at these low prices and i think will make even a bigger hit than last time when she hit 3 bucks,god bless all and good luck to us